First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Featuring an interview with Prof Martin Reck, including the following topics:

Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
Considerations with maintenance therapy for ES-SCLC (9:31)
Considerations with immunotherapy for ES-SCLC (13:12)
Curability of SCLC with systemic therapy (15:17)
Data with chemoimmunotherapy for patients with poor performance status (25:55)
Future developments in therapy for SCLC (30:11)
Rapid fire: Small Cell 101 (35:45)